Published in Medical Letter on the CDC and FDA, May 26th, 2002
But they recommended that it be prescribed only by doctors who have undergone special training to use it, and given only to the sickest patients, who must register in a national database that will track how they fare.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.